Literature DB >> 4040038

Further evidence that big,big prolactin is preferentially secreted in women with hyperprolactinemia and normal ovarian function.

F Larrea, C Villanueva, M Carmen Cravioto, A Escorza, O del Real.   

Abstract

The heterogeneity of human serum prolactin (PRL) in 12 women with hyperprolactinemia and different derangements of the hypothalamic-pituitary-ovarian axis was studied. The patients were subdivided into three groups: four women with hyperprolactinemia and normal ovarian function (group I), four women with hyperprolactinemia associated with sporadic endometrial bleedings and a positive progestin test (group II), and four women with amenorrhea and a negative progestin test (group III). Gel filtration chromatography of serum samples from patients in group I revealed in three of them that most (80%) of their immunoreactive PRL eluted as big,big PRL (Mr greater than 100,000); whereas the rest of the patients, including those from groups II and III, exhibited a distribution pattern similar to that obtained in normal menstruating women. All PRL species had similar affinities for the antibody, as disclosed by the slopes generated in dose-response curves. These results indicate that ovarian function in hyperprolactinemia might be dependent upon PRL heterogeneity and suggest that big,big PRL may have, under in vivo conditions, a low degree of biologic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040038

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Three cases of macroprolactinaemia.

Authors:  A O Olukoga; T L Dornan; J W Kane
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

2.  Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia.

Authors:  H Tamai; O Mizuno; A Takaki; K Kiyohara; G Komaki; S Matsubayashi; K Kuma; L F Kumagai; S Nagataki
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

3.  Clinical and radiological findings in macroprolactinemia.

Authors:  Serhat Isik; Dilek Berker; Yasemin Ates Tutuncu; Ufuk Ozuguz; Ferhat Gokay; Gonul Erden; Hatice Nursun Ozcan; Ferit Kerim Kucukler; Yusuf Aydin; Serdar Guler
Journal:  Endocrine       Date:  2011-12-21       Impact factor: 3.633

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

5.  Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.

Authors:  M E Fonseca; R Ochoa; C Morán; A Zárate
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

Review 6.  Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis.

Authors:  Noor Azlin Azraini Che Soh; Najib Majdi Yaacob; Julia Omar; Aniza Mohammed Jelani; Noorazliyana Shafii; Tuan Salwani Tuan Ismail; Wan Norlina Wan Azman; Anis Kausar Ghazali
Journal:  Int J Environ Res Public Health       Date:  2020-11-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.